By
Marissa Chmiola
Published: Aug. 22, 2014, 12:29 p.m.·
Tags:
Treatment,
Drug-resistant TB
Laia Ruiz Mingote and Dorothy Namutamba—co-chairs of CRAG— and Mike Watson Frick—TB/HIV Program Officer at Treatment Action Group—discuss the benefits and risks of using bedaquiline to treat TB.
Read More →
By
Novartis
Published: Aug. 20, 2014, 4:10 p.m.·
Tags:
Scientific research,
Research and development
Exclusive worldwide license from Novartis includes a novel class of drugs that is active against drug sensitive and multi-resistant strains of tuberculosis.
Read More →
By
Pavol Stracansky
Published: Aug. 20, 2014, 1:32 p.m.·
Tags:
Access
Ukraine has one of the worst TB problems in Europe, second only to Russia in terms of infection numbers. It is one of 27 high MDR-TB burden countries in the world.
Read More →
By
World Health Organization
Published: Aug. 17, 2014, 8:09 p.m.·
Tags:
TB programs
The handbook shows how to use various data sources, presents existing tools to analyse the quality of data and describes methods to estimate the burden of TB and related trends.
Read More →
By
Global Coalition of TB Activists
Published: Aug. 5, 2014, 3:04 p.m.·
Tags:
Advocacy
The GCTA is a coalition of representatives from and of the TB affected communities aiming to bring together activists from diverse backgrounds and regions to ensure TB affected communities are at the center of all processes on TB.
Read More →
By
ATAC,
Community Research Advisors Group (CRAG),
European AIDS Treatment Group (EATG),
TB CAB
Published: Aug. 1, 2014, 9:25 p.m.·
Tags:
Advocacy,
TB CAB,
CRAG
Several community groups express concerns regarding the STREAM stage II trial design for bedaquiline approval.
Read More →
By
ACTION
Published: July 24, 2014, 3:25 p.m.·
Tags:
HIV coinfection,
Global TB response,
Advocacy
A new research report from ACTION global health shows that joint TB-HIV activities are neglected by HIV programs and overwhelmingly carried out by TB programs, and that global guidelines to address TB-HIV have not been prioritized by leading donors and affected countries.
Read More →
By
HIV i-Base,
Treatment Action Group
Published: July 20, 2014, 3:59 p.m.·
Tags:
Hepatitis C,
Prevention,
Vaccines,
Pediatrics,
Advocacy
Latest annual review on pipeline drugs for adults and children, strategies for cure and prevention for HIV, HCV, TB and vaccine research.
Read More →
By
Volha Charnysh
Published: July 14, 2014, 9:48 p.m.·
Tags:
TB epidemiology,
Drug-resistant TB,
Mobile populations
Research indicates that post-Soviet migrants account for a mere 1.7% of TB incidence across the EU border. Portraying migrants from post-Soviet states as diseased may contribute to their already negative perception in Western Europe and will further strengthen prejudice against this group.
Read More →
By
Pavol Stracansky
Published: July 14, 2014, 8:15 p.m.·
Tags:
TB epidemiology,
Drug-resistant TB,
TB programs,
Global TB response,
Correctional facilities
TB is a major health threat in Russia, where it is the leading infectious disease killer. The country has the highest rates of MDR-TB and XDR-TB in Europe and the third highest in the world. It also has the 11th highest burden of all TB in the world.
Read More →
Page 90 of 131 · Total posts: 10
←First
89
90
91
Last→